{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T11:05:06Z","timestamp":1784199906161,"version":"3.55.0"},"reference-count":25,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T00:00:00Z","timestamp":1483574400000},"content-version":"vor","delay-in-days":645,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,4,1]]},"abstract":"<jats:sec>\n                  <jats:title>Context:<\/jats:title>\n                  <jats:p>PAPSS2 (PAPS synthase 2) provides the universal sulfate donor PAPS (3\u2032-phospho-adenosine-5\u2032-phosphosulfate) to all human sulfotransferases, including SULT2A1, responsible for sulfation of the crucial androgen precursor dehydroepiandrosterone (DHEA). Impaired DHEA sulfation is thought to increase the conversion of DHEA toward active androgens, a proposition supported by the previous report of a girl with inactivating PAPSS2 mutations who presented with low serum DHEA sulfate and androgen excess, clinically manifesting with premature pubarche and early-onset polycystic ovary syndrome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients and Methods:<\/jats:title>\n                  <jats:p>We investigated a family harboring two novel PAPSS2 mutations, including two compound heterozygous brothers presenting with disproportionate short stature, low serum DHEA sulfate, but normal serum androgens. Patients and parents underwent a DHEA challenge test comprising frequent blood sampling and urine collection before and after 100 mg DHEA orally, with subsequent analysis of DHEA sulfation and androgen metabolism by mass spectrometry. The functional impact of the mutations was investigated in silico and in vitro.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>We identified a novel PAPSS2 frameshift mutation, c.1371del, p.W462Cfs*3, resulting in complete disruption, and a novel missense mutation, c.809G&amp;gt;A, p.G270D, causing partial disruption of DHEA sulfation. Both patients and their mother, who was heterozygous for p.W462Cfs*3, showed increased 5\u03b1-reductase activity at baseline and significantly increased production of active androgens after DHEA intake. The mother had a history of oligomenorrhea and chronic anovulation that required clomiphene for ovulation induction.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>We provide direct in vivo evidence for the significant functional impact of mutant PAPSS2 on DHEA sulfation and androgen activation. Heterozygosity for PAPSS2 mutations can be associated with a phenotype resembling polycystic ovary syndrome.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2014-3556","type":"journal-article","created":{"date-parts":[[2015,1,16]],"date-time":"2015-01-16T17:41:04Z","timestamp":1421430064000},"page":"E672-E680","source":"Crossref","is-referenced-by-count":71,"title":["PAPSS2 Deficiency Causes Androgen Excess via Impaired DHEA Sulfation\u2014In Vitro and in Vivo Studies in a Family Harboring Two Novel PAPSS2 Mutations"],"prefix":"10.1210","volume":"100","author":[{"given":"Wilma","family":"Oostdijk","sequence":"first","affiliation":[{"name":"Department of Pediatrics (W.O., M.C.d.V., J.M.W.), Leiden University Medical Center, 2300 RC Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Idkowiak","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism (J.I., J.W.M., P.J.H., A.E.T., M.W.O., B.A.H., W.A.), School of Clinical and Experimental Medicine, University of Birmingham, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.","family":"Mueller","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism (J.I., J.W.M., P.J.H., A.E.T., M.W.O., B.A.H., W.A.), School of Clinical and Experimental Medicine, University of Birmingham, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"House","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism (J.I., J.W.M., P.J.H., A.E.T., M.W.O., B.A.H., W.A.), School of Clinical and Experimental Medicine, University of Birmingham, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela E.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism (J.I., J.W.M., P.J.H., A.E.T., M.W.O., B.A.H., W.A.), School of Clinical and Experimental Medicine, University of Birmingham, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"O'Reilly","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism (J.I., J.W.M., P.J.H., A.E.T., M.W.O., B.A.H., W.A.), School of Clinical and Experimental Medicine, University of Birmingham, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly A.","family":"Hughes","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism (J.I., J.W.M., P.J.H., A.E.T., M.W.O., B.A.H., W.A.), School of Clinical and Experimental Medicine, University of Birmingham, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine C.","family":"de Vries","sequence":"additional","affiliation":[{"name":"Department of Pediatrics (W.O., M.C.d.V., J.M.W.), Leiden University Medical Center, 2300 RC Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarina G.","family":"Kant","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics (S.G.K., G.W.E.S., M.L.), Leiden University Medical Center, 2300 RC Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gijs W. E.","family":"Santen","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics (S.G.K., G.W.E.S., M.L.), Leiden University Medical Center, 2300 RC Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke J. M. H.","family":"Verkerk","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (A.J.M.H.V., A.G.U.), Erasmus Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 G.","family":"Uitterlinden","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (A.J.M.H.V., A.G.U.), Erasmus Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M.","family":"Wit","sequence":"additional","affiliation":[{"name":"Department of Pediatrics (W.O., M.C.d.V., J.M.W.), Leiden University Medical Center, 2300 RC Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Losekoot","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics (S.G.K., G.W.E.S., M.L.), Leiden University Medical Center, 2300 RC Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Arlt","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism (J.I., J.W.M., P.J.H., A.E.T., M.W.O., B.A.H., W.A.), School of Clinical and Experimental Medicine, University of Birmingham, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071623172651100_B1","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1210\/jc.2004-2386","article-title":"No evidence for hepatic conversion of dehydroepiandrosterone (DHEA) sulfate to DHEA: in vivo and in vitro studies","volume":"90","author":"Hammer","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623172651100_B2","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2005-2258","article-title":"Dissociation of serum dehydroepiandrosterone and dehydroepiandrosterone sulfate in septic shock","volume":"91","author":"Arlt","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623172651100_B3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1530\/JOE-11-0266","article-title":"Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers","volume":"212","author":"Purohit","year":"2012","journal-title":"J Endocrinol"},{"key":"2020071623172651100_B4","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1056\/NEJMoa0810489","article-title":"Inactivating PAPSS2 mutations in a patient with premature pubarche","volume":"360","author":"Noordam","year":"2009","journal-title":"N Engl J Med"},{"key":"2020071623172651100_B5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/2458","article-title":"Mutations in orthologous genes in human spondyloepimetaphyseal dysplasia and the brachymorphic mouse","volume":"20","author":"Faiyaz Ul Haque","year":"1998","journal-title":"Nat Genet"},{"key":"2020071623172651100_B6","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/(SICI)1096-8628(19980806)78:5<468::AID-AJMG13>3.0.CO;2-D","article-title":"Distinct, autosomal recessive form of spondyloepimetaphyseal dysplasia segregating in an inbred Pakistani kindred","volume":"78","author":"Ahmad","year":"1998","journal-title":"Am J Med Genet"},{"key":"2020071623172651100_B7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/ajmg.a.33909","article-title":"Nosology and classification of genetic skeletal disorders: 2010 revision","volume":"155A","author":"Warman","year":"2011","journal-title":"Am J Med Genet A"},{"key":"2020071623172651100_B8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/jmedgenet-2012-101039","article-title":"PAPSS2 mutations cause autosomal recessive brachyolmia","volume":"49","author":"Miyake","year":"2012","journal-title":"J Med Genet"},{"key":"2020071623172651100_B9","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/ajmg.a.35906","article-title":"Spondyloepimetaphyseal dysplasia Pakistani type: expansion of the phenotype","volume":"161A","author":"T\u00fcys\u00fcz","year":"2013","journal-title":"Am J Med Genet A"},{"key":"2020071623172651100_B10","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/humu.22377","article-title":"Clinical and radiographic features of the autosomal recessive form of brachyolmia caused by PAPSS2 mutations","volume":"34","author":"Iida","year":"2013","journal-title":"Hum Mutat"},{"key":"2020071623172651100_B11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/ng.2217","article-title":"Mutations in SWI\/SNF chromatin remodeling complex gene ARID1B cause Coffin-Siris syndrome","volume":"44","author":"Santen","year":"2012","journal-title":"Nat Genet"},{"key":"2020071623172651100_B12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jmb.2005.01.005","article-title":"The crystal structure of human PAPS synthetase 1 reveals asymmetry in substrate binding","volume":"347","author":"Harjes","year":"2005","journal-title":"J Mol Biol"},{"key":"2020071623172651100_B13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.bbrc.2010.04.039","article-title":"A heterodimer of human 3\u2032-phospho-adenosine-5\u2032-phosphosulphate (PAPS) synthases is a new sulphate activating complex","volume":"395","author":"Grum","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071623172651100_B14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/prot.10104","article-title":"Increasing the precision of comparative models with YASARA NOVA\u2014a self-parameterizing force field","volume":"47","author":"Krieger","year":"2002","journal-title":"Proteins"},{"key":"2020071623172651100_B15","doi-asserted-by":"crossref","first-page":"17645","DOI":"10.1074\/jbc.M111.325498","article-title":"3\u2032-Phosphoadenosine 5\u2032-phosphosulfate (PAPS) synthases, naturally fragile enzymes specifically stabilized by nucleotide binding","volume":"287","author":"van den Boom","year":"2012","journal-title":"J Biol Chem"},{"key":"2020071623172651100_B16","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1093\/bioinformatics\/btm404","article-title":"Clustal W and Clustal X version 2.0","volume":"23","author":"Larkin","year":"2007","journal-title":"Bioinformatics"},{"key":"2020071623172651100_B17","doi-asserted-by":"crossref","first-page":"e29559","DOI":"10.1371\/journal.pone.0029559","article-title":"Human PAPS synthase isoforms are dynamically regulated enzymes with access to nucleus and cytoplasm","volume":"7","author":"Schr\u00f6der","year":"2012","journal-title":"PLoS One"},{"key":"2020071623172651100_B18","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1210\/jcem.83.6.4850","article-title":"Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression","volume":"83","author":"Arlt","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623172651100_B19","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1210\/jc.2002-021875","article-title":"Beyond adrenal and ovarian androgen generation: increased peripheral 5 \u03b1-reductase activity in women with polycystic ovary syndrome","volume":"88","author":"Fassnacht","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623172651100_B20","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jc.2013-3399","article-title":"Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione","volume":"99","author":"O'Reilly","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623172651100_B21","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1373\/clinchem.2010.143222","article-title":"Liquid chromatography-tandem mass spectrometry assay for androstenedione, dehydroepiandrosterone, and testosterone with pediatric and adult reference intervals","volume":"56","author":"Kushnir","year":"2010","journal-title":"Clin Chem"},{"key":"2020071623172651100_B22","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(04)16503-3","article-title":"Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study","volume":"363","author":"Arlt","year":"2004","journal-title":"Lancet"},{"key":"2020071623172651100_B23","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1210\/jcem.84.6.5789","article-title":"Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens","volume":"84","author":"Arlt","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071623172651100_B24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1530\/JME-12-0185","article-title":"A SULT2A1 genetic variant identified by GWAS as associated with low serum DHEAS does not impact on the actual DHEA\/DHEAS ratio","volume":"50","author":"Haring","year":"2013","journal-title":"J Mol Endocrinol"},{"key":"2020071623172651100_B25","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1210\/jc.2013-1976","article-title":"Variants in SULT2A1 affect the DHEA sulphate to DHEA ratio in patients with polycystic ovary syndrome but not the hyperandrogenic phenotype","volume":"98","author":"Louwers","year":"2013","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/100\/4\/E672\/20287661\/jcemE672.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/100\/4\/E672\/20287661\/jcemE672.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T12:06:53Z","timestamp":1594987613000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/100\/4\/E672\/2815175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,1]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2014-3556","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,1]]}}}